erythromycin lactobionate 500 MG Injection
- RxCUI
- 1668264
- RxNorm name
- erythromycin lactobionate 500 MG Injection
- Display name
- erythromycin lactobionate 500 MG Injection
- Full name
- erythromycin lactobionate 500 MG Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:14
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Erythromycin Lactobionate | ERYTHROMYCIN LACTOBIONATE | Piramal Critical Care Inc. | ee345752-0f0c-c69b-e053-2995a90a7dac | 2026-08-16 | Warnings, Adverse reactions | 1668264 |
| Erythromycin Lactobionate | ERYTHROMYCIN LACTOBIONATE | Armas Pharmaceuticals Inc. | ca65a48f-5fe6-4b31-8359-51dbc31f6d4e | 2026-07-09 | Warnings, Adverse reactions | 1668264 |
| Erythrocin Lactobionate | ERYTHROMYCIN LACTOBIONATE | Hospira, Inc. | a96c405f-bd70-4bb4-719e-ac6a79dcc213 | 2025-10-30 | Warnings, Adverse reactions | 1668264 |
| erythromycin lactobionate | ERYTHROMYCIN LACTOBIONATE | Gland Pharma Limited | c6f9565b-6d9d-40e3-87f8-9f38ede9173a | 2024-11-20 | Warnings, Adverse reactions | 1668264 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a96c405f-bd70-4bb4-719e-ac6a79dcc213 | erythromycin lactobionate 500 MG Injection [PSN] · erythromycin lactobionate 500 MG Injection [SCD] | 2 | 25 | Erythrocin™ Lactobionate - IV | 20251030 |
| c6f9565b-6d9d-40e3-87f8-9f38ede9173a | erythromycin lactobionate 500 MG Injection [PSN] · erythromycin lactobionate 500 MG Injection [SCD] | 2 | 4 | Rx only Erythromycin Lactobionate for Injection, USP INTRAVENOUS USE ONLY Single-Dose Vials To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin and other antibacterial drugs, erythromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20241120 |